FDA lifts hold on first human CRISPR trial

17-10-2018

FDA lifts hold on first human CRISPR trial

sudok1 / iStockphoto.com

The US Food and Drug Administration (FDA) has allowed the first US-based human trial of CRISPR, the gene-editing technology, to proceed.


Food and Drug Administration, CRISPR, gene-editing technology, CRISPR Therapeutics, Vertex Pharmaceutics, sickle cell disease, β-thalassemia, study

LSIPR